dsip peptide benefits and side effects Effect of analogues on the toxicity of cispll atin* DSIP (5mg vials) - Peptide
Description
Advanced / Aggressive Approach (3 mL = ~6,667 mcg/mL) Advanced daily dose: 500 mcg total blend once daily ~8 units on a 20 mg vial, ~15 units on a 10 mg vial
As of mid-2026, no published human clinical trials exist for 5-Amino-1MQ specifically
While still in preclinical stages, the SOCS1 peptide represents an important conceptual advance in targeted autoimmune therapy
Siegall et al., 1994
They may carry different risks but are not inherently safe. Both classes alter hormonal signaling pathways
